Alnylam Pharmaceuticals (ALNY) Work In Process (2018 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Work In Process of $59.05 million in Q2 2026, up 34.9% from $43.78 million a year earlier but down 9.8% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Work In Process (2018 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals reported Work In Process of $65.12 million, up 0.2% from FY2024.
- Annual Work In Process has a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
- Across earlier years, Work In Process came in at $64.98 million in FY2024 (-15.6%), $76.96 million in FY2023 (-32.4%), $113.78 million in FY2022 (+12.7%) and $100.94 million in FY2021 (+525.1%).
- Quarterly Work In Process has ranged from $33.12 million in Q3 2021 to $116.66 million in Q2 2023 over the past five years.
- On a year-over-year basis, Work In Process has increased for three consecutive quarters, with an average decline of 11.6% over the last eight quarters.
- Peak year-over-year performance for Work In Process in the last five years was growth of 525.1% in Q4 2021, against a decline of 49.2% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $65.46 million (Q1 2026), $65.12 million (Q4 2025) and $35.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.05 Mn |
| Mar 31, 2026 | 65.46 Mn |
| Dec 31, 2025 | 65.12 Mn |
| Sep 30, 2025 | 35.50 Mn |
| Jun 30, 2025 | 43.78 Mn |
| Mar 31, 2025 | 53.99 Mn |
| Dec 31, 2024 | 64.98 Mn |
| Sep 30, 2024 | 69.87 Mn |
| Jun 30, 2024 | 66.54 Mn |
| Mar 31, 2024 | 76.07 Mn |
| Dec 31, 2023 | 76.96 Mn |
| Sep 30, 2023 | 88.69 Mn |
| Jun 30, 2023 | 116.66 Mn |
| Mar 31, 2023 | 110.98 Mn |
| Dec 31, 2022 | 113.78 Mn |
| Sep 30, 2022 | 102.45 Mn |
| Jun 30, 2022 | 100.19 Mn |
| Mar 31, 2022 | 91.26 Mn |
| Dec 31, 2021 | 100.94 Mn |
| Sep 30, 2021 | 33.12 Mn |
API Access
Alnylam Pharmaceuticals Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();